Clinical Trials in Colorado

Showing 2801-2820 of 8,657 trials

COMPLETED50 miles

Perfusion Index Parameter

NCT06586918

To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.

Perfusion; Complications

Medtronic - MITG32 participantsStarted Sep 2024

Denver, Colorado, United States

COMPLETEDNA53 miles

"Safety in Dementia": An Online Caregiver Intervention

NCT05173922

In an online randomized trial of Safety in Dementia with national recruitment and longitudinal follow-up, we will recruit informal caregivers of community-dwelling adults with dementia who have firearm access.

CaregiversDecision MakingAlzheimer Disease+3 more

University of Colorado, Denver500 participantsStarted May 2022

Aurora, Colorado, United States

COMPLETED53 miles

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

NCT03733418

This ancillary study will determine if early administration of a single high-dose (540,000 IU) oral vitamin D3 (cholecalciferol) treatment improves 12-month global cognition and executive function as determined by comprehensive neuropsychological testing in 140 critically ill patients with Vitamin D deficiency at enrollment.

Cognitive Decline

Vanderbilt University Medical Center95 participantsStarted Nov 2018

Aurora, Colorado, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +4 more locations

Perfusion Index Parameter

"Safety in Dementia": An Online Caregiver Intervention

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Find Trials by Condition in Colorado

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

A Study of LY3022855 In Participants With Breast or Prostate Cancer

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms